drugset / Trial / NCT01095094

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

NCT01095094

Phase 2 Terminated 19 enrolled Case Comprehensive Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well giving ritonavir together with lopinavir works in treating patients with progressive or recurrent high-grade glioma.

Timeline

Start
2009-01
Primary completion
2010-06
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lopinavir Other / unclassified Oral
Subject Ritonavir Other / unclassified Oral